You're pretty good at the "chart stuff." That was a great call on the "$10.60 support." Like to see us go through $13.again. That would be real nice.
Now that I think about it, I do remember you posting that question. With approval looking almost like a "lock," it seems like this is a case of "one in the hand is worth two in the bush,"
It's amazing. Rose pays himself over $1 million a year , the company has over $100 million in cash, bur he can't get the stock price to $4. Hard to believe!
Durata has a market cap of around $280 million. Tetraphase Pharma has a market cap of around $360 million. Dalbavancin will probably be approved this year. When comparing the 2 companies, it doesn't make much sense to me why Tetraphase Pharma has the larger market cap. Seems to me, it should be the other way around.
"Both sides have dug their heels in the sand."
Sounds like the Democrats VS the Republicans!